Abstract:Recent discovery of induced pluripotent stem cells (iPSCs) open the great possibility to use patient own tissue to the previously incurable diseases. Multipotent adult stem/progenitor cells have been identified in nearly all human organs. These cells are expanded in vitro and are possible to be used for personalized cell therapy. This special issue collected the articles which discussed recent progresses in this field. Our body has self-defense systems to recover from damages. However, once tissues are damaged extensively, damaged tissues cannot be recovered. These include hepatic (C. H. Chiang, M. A. Puglisi), kidney, lung, and heart failures. Also in neurodegenerative diseases including Parkinson's disease, Alzheimer diseases, and ALS, patient cells are difficult to recover (H. Y. Ha). External stimuli such as high dose of irradiation caused by cancer treatment (B. Phulpin) will induce irreversible damages. There exist genetic disorders for which there is no cure including progressive muscular dystrophies (E. Zucconi), cystic fibrosis (V. Paracchini). Further age-related dysfunctions are difficult to be recovered. One example is articular cartilage (S. Seo). Currently transplantation has been shown to be an effective treatment for these tissue failures. However, transplantation has serious problems: shortage of organs to be transplanted and immune rejection caused by great heterogeneity of human HLA. Recent progresses of biotechnology open a new hope to treat incurable diseases by using patient own tissues. This special issue aimed to gather scientific papers about recent progresses in this field. iPSCs are novel stem cell populations induced from mouse and human adult somatic cells through reprogramming by transduction of defined transcription factors. These cells open the great possibility to personalized cell therapy to treat incurable diseases (K. Seiler, T. Kunkanjanawan, H. Y. Ha). Compared to ES cells, iPSCs are not rejected by host immune cells theoretically. At least iPS cells are not rejected once these cells are differentiated (C. H. Chiang). Mesenchymal stromal cells (MSCs) from various sources including bone marrow (S. W. Gendebien), adipose tissue (W. Lattanzi), dental pulp, placenta, umbilical cord (E. Zucconi, S. Park), menstrual blood (M. C. Rodrigues) and amniotic mesenchymal stromal cells (V. Paracchini) have been studied extensively by animal models. Tissue stem cells are also used for personalized stem cell therapy. Muscle-derived stem cells for bone formation (X. Li), blood vessel-derived stem cells regenerate myofibers in injured and dystrophic skeletal muscles as well as improve cardiac function after myocardial infarction (C. W. Chen). Olfactory ensheathing cells (OECs) into nerve or spinal cord injuries can promote axonal regeneration and remyelination and restore functional recovery (C. Radtke). Some stem-like cells reside in the transition area between the peripheral corneal endothelium (CE) and the anterior nonfiltering portion of the trabecular meshwork (TM) replacing the lost CE (W. Y. Yu). Cell culture on scaffold enhances cell growth and differentiation. Hydroxyapatite (HA) coating of (PCL/PVA) nanofibers enhances bone repair (E. Prosecka). There are a number of reports for limitations of current technologies that hinder iPSCs into practical use. Immunogenicity to syngeneic mice and tumor formation are reported. MSCs also might promote tumor growth. MSCs immunomodulatory properties affect greatly the host. More works are sure to be needed to overcome these problems.

Stem cell-based therapy for human diseases

Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities

Application of mesenchymal stem cells derived from human pluripotent stem cells in regenerative medicine

Human Umbilical Cord Mesenchymal Stem Cells: an Overview of Their Potential in Cell-Based Therapy

Mesenchymal Stem Cells: a New Trend for Cell Therapy

Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases

Human mesenchymal stem cells: From immunophenotyping by flow cytometry to clinical applications

Mesenchymal stem cells: Cell therapy and regeneration potential

Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction

Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials

Toward Personalized Cell Therapies by Using Stem Cells 2013

Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications

What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?

Concise Review: Mesenchymal Stem Cells Derived from Human Pluripotent Cells, an Unlimited and Quality-Controllable Source for Therapeutic Applications

Role of Human Mesenchymal Stem Cells in Regenerative Therapy

Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy

Mesenchymal Stem Cells: Diseases and Cure

Perspectives on Stem Cell-Based Regenerative Medicine with a Particular Emphasis on Mesenchymal Stem Cell Therapy

Challenges and Controversies in Human Mesenchymal Stem Cell Therapy

Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review

Human Umbilical Cord Mesenchymal Stem Cells: A New Era for Stem Cell Therapy